Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma.
about
Advances in targeted proteomics and applications to biomedical researchMonitoring of the Immune Dysfunction in Cancer PatientsToward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.The utility of Apc-mutant rats in modeling human colon cancer.Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke.THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer.A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Development of a multiplexed assay for oral cancer candidate biomarkers using peptide immunoaffinity enrichment and targeted mass spectrometry.Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification.Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential.An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.Lectins: an effective tool for screening of potential cancer biomarkers.A targeted proteomics approach to the quantitative analysis of ERK/Bcl-2-mediated anti-apoptosis and multi-drug resistance in breast cancer.
P2860
Q28066912-B07C356F-3169-442A-B42B-480AD94E9AE8Q28072712-833E71B9-239E-461F-8349-1861694A5369Q34359998-1C8C1472-43BB-4C4C-A6C5-7A98970C9DCAQ34424145-D9A2AEA7-926D-46DE-93B0-40F272903D7DQ36846913-FE5AEEA8-9136-45F3-B2AD-8874BECDF21FQ37261166-6C1CA391-07A2-4EE8-8368-624E6D5991E2Q37648226-E294729E-4E71-444B-B804-A032DE64E17DQ38203040-A69AD0C1-0B49-416B-9D09-9D0A141A5DD1Q38547265-69DD7E55-C8F8-431A-89AA-ECACB0AFE3A4Q38604366-3999389C-8836-4552-AB28-D38300D4E137Q38640227-C791216D-005D-4C4E-9F5F-26C858B0A966Q38839133-EA3E9E81-6001-4470-8BB9-807986B5C30FQ39657160-94861A39-E15E-4401-9FDF-348C021E9699Q47941297-0EBA1BBF-B31F-4A61-84CD-8F5160113D10Q47954074-C471CAA1-83B5-4FEE-83B7-FFC73CF01151Q51579847-2E687280-22C4-4410-8915-1610ECAB5F43
P2860
Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Comparison of protein immunopr ...... iomarker candidates in plasma.
@en
Comparison of protein immunopr ...... iomarker candidates in plasma.
@nl
type
label
Comparison of protein immunopr ...... iomarker candidates in plasma.
@en
Comparison of protein immunopr ...... iomarker candidates in plasma.
@nl
prefLabel
Comparison of protein immunopr ...... iomarker candidates in plasma.
@en
Comparison of protein immunopr ...... iomarker candidates in plasma.
@nl
P2093
P2860
P356
P1476
Comparison of protein immunopr ...... biomarker candidates in plasma
@en
P2093
Robbert J C Slebos
William E Alborn
P2860
P304
P356
10.1021/PR400877E
P577
2013-11-19T00:00:00Z